Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease

Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic drivers of disease.
The system predicts how DNA mutations disrupt gene regulation across different tissues.
AlphaGenome can analyse up to one million DNA letters simultaneously.
Researchers trained the model on large human and mouse genetics databases.
The tool targets mutations linked to cancer, heart disease, autoimmune disorders, and mental illness.
Scientists say it could accelerate drug discovery and gene therapy design.
Experts from University of British Columbia and University College London called it a major advance in genome research.